Skip to main content
. 2019 Apr 1;142(5):1310–1323. doi: 10.1093/brain/awz054

Table 6.

Likelihood (%) of developing attacks and disability over the next 5 years for patients who are on IST from disease onset and who have not reached the endpoint but experienced one attack within 2 years since disease onset

Ethnicity and sex Japanese female Japanese male Caucasian female Caucasian male African female African male
Attack Risk over next 5 years Risk over next 5 years Risk over next 5 years Risk over next 5 years Risk over next 5 years Risk over next 5 years
Onset age, years Onset type 2nd type All EDSS 6.0 Blind All EDSS 6.0 Blind All EDSS 6.0 Blind All EDSS 6.0 Blind All EDSS 6.0 Blind All EDSS 6.0 Blind
≤35 ON ON 69.0 7.1 20.1 66.4 5.1 13.8 79.1 7.9 21.2 76.4 5.7 14.7 77.7 7.7 31.4 75.2 5.7 22.7
TM ON 68.6 12.1 6.4 64.4 8.6 4.2 78.9 13.4 6.8 74.9 9.7 4.5 78.2 13.8 11.1 74.1 10.2 7.5
BS ON 77.1 7.9 7.0 74.4 5.5 4.5 84.4 9.0 7.6 81.7 6.4 5.0 84.0 9.2 12.4 81.2 6.6 8.3
ON TM 66.9 7.3 20.6 62.5 5.3 14.2 77.7 8.1 21.8 73.5 6.0 15.3 76.2 7.9 32.0 72.2 6.0 23.5
TM TM 68.4 12.2 6.5 62.6 8.8 4.3 78.9 13.6 6.9 73.6 10.0 4.6 78.1 14.0 11.3 72.8 10.4 7.7
BS TM 76.1 8.1 7.2 72.1 5.7 4.7 83.8 9.2 7.8 80.0 6.6 5.2 83.4 9.5 12.7 79.4 6.9 8.6
ON BS 64.2 7.3 20.6 60.7 5.3 14.1 74.6 8.3 22.0 70.9 6.1 15.4 73.0 8.1 32.4 69.4 6.1 23.6
TM BS 65.3 12.2 6.5 60.4 8.7 4.2 75.5 13.9 7.0 70.6 10.1 4.7 74.7 14.3 11.5 69.6 10.5 7.8
BS BS 74.9 7.8 7.0 71.9 5.4 4.5 81.8 9.2 7.8 78.4 6.5 5.1 81.3 9.5 12.7 77.8 6.8 8.5
36–48 ON ON 65.2 11.1 18.1 62.0 8.1 12.3 75.4 12.5 19.3 72.2 9.2 13.3 74.5 12.2 28.7 71.4 9.2 20.7
TM ON 64.8 18.0 5.5 60.3 13.2 3.6 75.3 20.2 6.0 70.8 15.0 4.0 74.9 20.7 9.8 70.2 15.5 6.6
BS ON 74.6 12.0 6.1 71.6 8.5 4.0 81.8 13.9 6.8 78.6 10.0 4.4 81.8 14.2 11.0 78.5 10.4 7.4
ON TM 63.6 11.3 18.4 58.7 8.3 12.7 74.4 12.8 19.7 69.6 9.5 13.7 73.3 12.5 29.2 68.6 9.5 21.3
TM TM 65.2 18.1 5.6 59.0 13.4 3.7 75.8 20.3 6.0 69.9 15.3 4.0 75.3 20.8 9.8 69.3 15.8 6.7
BS TM 74.0 12.2 6.2 69.7 8.8 4.1 81.4 14.1 6.9 77.1 10.3 4.6 81.5 14.4 11.2 77.0 10.7 7.6
ON BS 61.0 11.3 18.3 57.1 8.2 12.5 71.1 12.9 19.8 66.8 9.6 13.8 70.0 12.6 29.5 65.8 9.6 21.4
TM BS 62.2 18.1 5.6 57.1 13.2 3.6 72.2 20.6 6.1 66.7 15.3 4.1 71.7 21.1 10.0 66.1 15.9 6.8
BS BS 73.1 11.8 6.0 69.8 8.3 3.9 79.4 14.0 6.8 75.7 10.1 4.5 79.4 14.3 11.1 75.5 10.5 7.5
>48 ON ON 63.9 20.0 14.6 59.3 15.0 10.0 75.2 22.0 15.5 70.8 16.7 10.7 74.2 22.0 23.8 69.9 17.0 17.0
TM ON 64.1 29.8 4.2 58.2 22.8 2.8 75.5 32.5 4.5 70.0 25.4 3.0 74.9 33.4 7.4 69.3 26.3 5.1
BS ON 72.3 21.8 4.9 68.0 16.1 3.3 81.0 24.3 5.3 76.9 18.3 3.6 80.9 24.9 8.8 76.6 19.0 6.0
ON TM 64.2 20.1 14.7 57.9 15.2 10.2 75.6 22.2 15.6 69.9 17.1 10.9 74.5 22.1 23.9 68.8 17.3 17.3
TM TM 66.1 29.7 4.2 58.9 22.9 2.8 77.2 32.4 4.5 70.8 25.5 3.1 76.6 33.3 7.4 70.1 26.4 5.1
BS TM 73.1 21.9 5.0 67.5 16.3 3.3 81.8 24.4 5.4 76.6 18.6 3.6 81.6 25.0 8.8 76.3 19.3 6.0
ON BS 60.2 20.3 14.8 54.7 15.2 10.2 71.5 22.6 15.9 66.0 17.3 11.1 70.4 22.5 24.3 64.9 17.5 17.5
TM BS 61.9 29.9 4.2 55.4 22.9 2.8 72.9 33.1 4.6 66.6 25.9 3.1 72.3 34.0 7.6 65.8 26.8 5.2
BS BS 70.8 21.6 4.9 66.0 15.9 3.2 78.9 24.6 5.4 74.0 18.6 3.6 78.7 25.2 8.9 73.6 19.3 6.1

See Supplementary Table 5 for the full dataset.

BS = brainstem; ON = optic neuritis; TM = transverse myelitis.